Weili Zhao

44PUBLICATIONS

104CO-AUTHORS

Solid tumoursHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (44)

Sort by Publication Date:

|Jun 29, 2026

LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.

|Jun 29, 2026

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

|Jun 24, 2026

Tumor-infiltrating clonal hematopoiesis is associated with adverse clinical outcomes in diffuse large B-cell lymphoma.

|May 21, 2026

N6-methyladenosine reader IGF2BP2 in T-cell lymphoma.

|May 12, 2026

Laying the Foundation for Clinically Actionable Genomic Subtyping in Diffuse Large B-cell Lymphoma.

|Apr 14, 2026

CD28+ CD8+ Tem cells with a STAT1-dependent glucocorticoid receptor deficit contribute to steroid-refractory acute GVHD.

Zengkai Pan, Yujun Deng, Jingtao Huang

Pageof 8

Frequent Collaborators

Li Wang

Rong-Ji Mu

Jie Xiong

Hongjing Dou

Jiahao Chen

Qing Shi

Monica Balzarotti

Xiaojian Sun

Luca Ceriani

Emanuele Zucca

Frequent Collaborators

Li Wang

Rong-Ji Mu

Jie Xiong

Hongjing Dou